BNP Paribas Asset Management
BVS icon

BNP Paribas Asset Management’s Bioventus BVS Stock Holding History

BNP Paribas Asset Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-707
Closed -$5K – 1895
2025
Q2 		$5K Buy
+707
New +$5.01K ﹤0.01% 1984

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management's BVS Position: Q3 2025 in Review

BNP Paribas Asset Management sold out of Bioventus (BVS) in Q3 2025, closing a stake of 707 shares — an estimated $5K sold.

BNP Paribas Asset Management first reported a position in BVS in Q2 2025 and held it in 1 quarter. The position peaked at $5K in Q2 2025. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • BNP Paribas Asset Management reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Asset Management sold 707 Bioventus shares in Q3 2025, an estimated $5K.
  • BNP Paribas Asset Management first reported a position in Bioventus in Q2 2025 and held it in 1 quarter.
  • BNP Paribas Asset Management's Bioventus position peaked at $5K in Q2 2025.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on BNP Paribas Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.